|
1 Company |
|
5 Products |
|
5 Products |
|
5 Mechanisms of Action |
|
0 Trials |
|
10 News |
|
- | Enrollment change, Trial withdrawal, Trial primary completion date: Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy (clinicaltrials.gov) - May 8, 2017
P2, N=0, Withdrawn, Sponsor: Bing Shu
N=300 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Dec 2016 --> May 2017
- ||| Trial completion: Renal Osteodystrophy: A Fresh Approach (clinicaltrials.gov) - Jun 4, 2015
P=N/A, N=464, Completed, Sponsor: University of Kentucky
N=300 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Dec 2016 --> May 2017 Recruiting --> Completed
- |||| Enrollment open, Trial primary completion date: Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy (clinicaltrials.gov) - May 20, 2015
P2, N=300, Recruiting, Sponsor: Bing Shu
Recruiting --> Completed Not yet recruiting --> Recruiting | Trial primary completion date: Nov 2014 --> Dec 2016
- zoledronic acid / Generic mfg.
Trial completion date: Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation (clinicaltrials.gov) - May 15, 2014
P4, N=34, Completed, Sponsor: University of Sao Paulo General Hospital
Not yet recruiting --> Recruiting | Trial primary completion date: Nov 2014 --> Dec 2016 Trial completion date: Jul 2014 --> May 2014
- zoledronic acid / Generic mfg.
Trial completion: Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation (clinicaltrials.gov) - May 15, 2014
P4, N=34, Completed, Sponsor: University of Sao Paulo General Hospital
Trial completion date: Jul 2014 --> May 2014 Active, not recruiting --> Completed
- | pamidronate disodium / Generic mfg.
Trial completion: Osteopenia and Renal Osteodystrophy: Evaluation and Management (clinicaltrials.gov) - Feb 22, 2014
P4, N=0, Completed, Sponsor: Department of Veterans Affairs
Active, not recruiting --> Completed No longer recruiting --> Completed
- zoledronic acid / Generic mfg.
Enrollment closed: Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation (clinicaltrials.gov) - Jul 28, 2013
P4, N=34, Active, not recruiting, Sponsor: University of Sao Paulo General Hospital
No longer recruiting --> Completed Completed --> Active, not recruiting
- zoledronic acid / Generic mfg.
New P4 trial: Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation (clinicaltrials.gov) - Aug 27, 2012
P4, N=34, Active, not recruiting, Sponsor: University of Sao Paulo General Hospital
- | New P2 trial: Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy (clinicaltrials.gov) - Aug 13, 2012
P2, N=300, Not yet recruiting, Sponsor: Bing Shu